TABLE 2

MRI and 18F-FDG PET Data

MRI18F-FDG PET
ParameterControlFADControlFAD
EC
 Left0.08 (0.07)0.07 (0.05)1.31 (0.22) [1.45 (0.18)]1.02 (0.14) [1.14 (0.14)]*
 Right0.09 (0.03)0.07 (0.02)1.23 (0.14) [1.30 (0.06)]1.13 (0.14) [1.23 (0.05)]
Hip
 Left0.44 (0.09)0.39 (0.05)1.36 (0.06) [1.38 (0.06)]1.22 (0.13) [1.24 (0.13)]*
 Right0.58 (0.17)0.43 (0.05)1.32 (0.07) [1.33 (0.07)]1.19 (0.14) [1.21 (0.15)]
IPL
 Left1.05 (0.11)0.87 (0.21)*1.84 (0.31) [1.99 (0.25)]1.56 (0.13) [1.67 (0.13)]*
 Right1.08 (0.13)0.88 (0.18)1.87 (0.32) [1.99 (0.31)]1.55 (0.12) [1.66 (0.12)]*
PCC
 Left2.36 (0.61)2.22 (0.43)2.26 (0.23) [2.28 (0.23)]1.75 (0.16) [1.83 (0.18)]
 Right2.38 (0.26)2.19 (0.50)2.18 (0.12) [2.22 (0.34)]1.79 (0.19) [1.86 (0.18)]
STG
 Left3.47 (0.92)3.39 (0.69)1.64 (0.19) [1.76 (0.20)]1.43 (0.13) [1.57 (0.16)]*
 Right3.72 (0.65)3.41 (0.40)1.69 (0.18) [1.83 (0.21)]1.47 (0.09) [1.62 (0.11)]*
WB4.82 (1.6)3.71 (0.9)1.66 (0.14) [1.78 (0.15)]1.43 (0.12) [1.55 (0.13)]*
Ventricular CSF (mL)16.5 (5.7)14.3 (4.4)
HS (cm3)1,239 (94)1,212 (114)
Pons MRglc1,121 (427) [1,137 (439)]1,239 (420) [1,245 (342)]
  • * P ≤ 0.05, FAD < control subjects.

  • P ≤ 0.01, FAD < control subjects.

  • MRI measures = (ROI/HS volumes) × 100; 18F-FDG PET measures = ROI/pons MRglc; MRglc = glucose metabolism (overall count rate).

  • Values are means (SD) [atrophy-corrected MRglc values].